Compile Data Set for Download or QSAR
maximum 50k data
Found 9 of ki for monomerid = 242431
TargetCannabinoid receptor 2(Homo sapiens (Human))
Pharmos

US Patent
LigandPNGBDBM242431(US9422235, 4)
Affinity DataKi:  19nM ΔG°:  -10.7kcal/mole IC50:  37nMT: 2°CAssay Description:The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Pharmos

US Patent
LigandPNGBDBM242431(US9422235, 4)
Affinity DataKi:  29nM ΔG°:  -10.4kcal/mole IC50:  56nMT: 2°CAssay Description:The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Pharmos

US Patent
LigandPNGBDBM242431(US9422235, 4)
Affinity DataKi:  29.2nM ΔG°:  -10.4kcal/mole IC50:  58.1nMT: 2°CAssay Description:The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Pharmos

US Patent
LigandPNGBDBM242431(US9422235, 4)
Affinity DataKi:  34nM ΔG°:  -10.4kcal/mole IC50:  76nMT: 2°CAssay Description:The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Pharmos

US Patent
LigandPNGBDBM242431(US9422235, 4)
Affinity DataKi:  37nM ΔG°:  -10.3kcal/mole IC50:  68nMT: 2°CAssay Description:The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCannabinoid receptor 1(Homo sapiens (Human))
Pharmos

US Patent
LigandPNGBDBM242431(US9422235, 4)
Affinity DataKi:  260nM ΔG°:  -9.13kcal/mole IC50:  580nMT: 2°CAssay Description:The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCannabinoid receptor 1(Homo sapiens (Human))
Pharmos

US Patent
LigandPNGBDBM242431(US9422235, 4)
Affinity DataKi:  400nM ΔG°:  -8.87kcal/mole IC50:  720nMT: 2°CAssay Description:The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCannabinoid receptor 1(Homo sapiens (Human))
Pharmos

US Patent
LigandPNGBDBM242431(US9422235, 4)
Affinity DataKi:  1.16E+3nM ΔG°:  -8.23kcal/mole IC50:  2.00E+3nMT: 2°CAssay Description:The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCannabinoid receptor 1(Homo sapiens (Human))
Pharmos

US Patent
LigandPNGBDBM242431(US9422235, 4)
Affinity DataKi:  1.56E+3nM ΔG°:  -8.05kcal/mole IC50:  3.06E+3nMT: 2°CAssay Description:The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent